23 February 2019 - 19:09
News Code 83219876
0 Persons
Rheumatoid arthritis treatment drug produced in Iran

Tehran, Feb 23, IRNA - The head of the Iranian Rheumatology Research Center announced the production of the drug to treat rheumatoid arthritis by Iranian researchers. The quality of this drug is similar to the foreign one and it stops the process of developing the disease.

At the opening ceremony of the drug, Ahmad Reza Jamshidi highlighted, “This drug is being used to treat the disease of rheumatoid arthritis. Of course, a few years ago, the foreign type of the drug entered the country, but because of the high cost that we could not prescribe to the patient and the patient was not able to pay for the drug. Also, no insurance covers this medication, because it is a chronic disease and has a long treatment period, and as a result we had to produce it in the country.'

Nima Sepehri, director of the pharmaceutical company that produced the medicine, also said about the drug, 'For the first time, we succeeded in producing 'Tofacitinib' in the country. This drug is being used for patients with rheumatoid arthritis and psoriatic arthritis and patients with moderate to severe ulcerative colitis.'

9455**2050

Follow us on Twitter @IrnaEnglish